Ratna B Ray Selected Research

momordicine I

3/2021

Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ratna B Ray Research Topics

Disease

34	Infections 01/2022 - 12/2003
28	Neoplasms (Cancer) 06/2022 - 11/2002
11	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 10/2003
11	Liver Diseases (Liver Disease) 01/2019 - 06/2006
9	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 11/2002
7	Squamous Cell Carcinoma of Head and Neck 04/2019 - 01/2013
7	Breast Neoplasms (Breast Cancer) 11/2018 - 04/2002
6	Fibrosis (Cirrhosis) 10/2019 - 09/2013
5	Mouth Neoplasms (Oral Cancer) 01/2022 - 01/2018
5	Neoplasm Metastasis (Metastasis) 07/2020 - 04/2010
4	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 09/2013
4	Disease Progression 03/2015 - 06/2005
3	Inflammation (Inflammations) 01/2022 - 11/2013
3	COVID-19 01/2022 - 12/2020
3	Chronic Hepatitis C 01/2021 - 09/2013
3	Persistent Infection 01/2014 - 04/2008
3	Carcinogenesis 07/2011 - 11/2008
2	Obesity 06/2022 - 01/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 03/2021
2	Tongue Neoplasms (Tongue Neoplasm) 12/2020 - 01/2018
2	Viremia 10/2019 - 01/2019
2	Virus Diseases (Viral Diseases) 07/2014 - 07/2002
2	Insulin Resistance 06/2012 - 03/2008
2	Necrosis 12/2006 - 08/2004
1	Alcoholic Fatty Liver 01/2021
1	Retinoblastoma (Glioblastoma, Retinal) 12/2020
1	Hypoxia (Hypoxemia) 07/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020
1	Tics (Tic) 01/2020
1	Hepatitis C 01/2020

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 12/2020 - 04/2002
13	MicroRNAs (MicroRNA)IBA 11/2019 - 04/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 04/2002
6	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2003
6	Antiviral Agents (Antivirals)IBA 10/2019 - 11/2007
6	InterferonsIBA 03/2015 - 01/2007
5	Long Noncoding RNAIBA 01/2022 - 04/2019
5	CytokinesIBA 03/2021 - 05/2010
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2013
4	CCAAT-Enhancer-Binding ProteinsIBA 10/2021 - 07/2014
4	Small Interfering RNA (siRNA)IBA 12/2020 - 08/2006
4	Cyclin D1IBA 01/2020 - 04/2005
3	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 06/2012
3	LigandsIBA 03/2021 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 03/2021 - 05/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 05/2006
3	CollagenIBA 01/2020 - 04/2010
3	mouse MIRN29 microRNAIBA 11/2019 - 04/2010
3	LipidsIBA 10/2019 - 11/2002
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2017
3	Poly I-CIBA 01/2014 - 11/2007
3	CaspasesIBA 02/2011 - 02/2005
2	CholesterolIBA 06/2022 - 11/2018
2	Transcription Factors (Transcription Factor)IBA 06/2022 - 10/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 08/2013
2	VaccinesIBA 01/2022 - 01/2019
2	InflammasomesIBA 01/2022 - 01/2017
2	ChemokinesIBA 03/2021 - 01/2017
2	Fibrinogen (Factor I)FDA Link 03/2021 - 05/2010
2	Complex MixturesIBA 01/2021 - 07/2020
2	CarcinogensIBA 10/2019 - 01/2018
2	GelsolinIBA 04/2018 - 10/2017
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2017 - 01/2017
2	Neutralizing AntibodiesIBA 12/2017 - 01/2017
2	Immunologic Factors (Immunomodulators)IBA 05/2016 - 09/2009
2	Antineoplastic Agents (Antineoplastics)IBA 12/2011 - 03/2010
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2011 - 03/2010
2	Caspase 9IBA 07/2011 - 04/2002
2	Interferon-betaIBA 11/2010 - 11/2007
2	Viral ProteinsIBA 09/2010 - 06/2010
2	Androgen Receptors (Androgen Receptor)IBA 08/2010 - 11/2008
2	AndrogensIBA 11/2008 - 04/2005
2	Cytochromes c (Cytochrome c)IBA 12/2006 - 04/2002
1	Mechanistic Target of Rapamycin Complex 2IBA 06/2022
1	DextrinsIBA 06/2022
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 11/2021
1	capivasertibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	ChromatinIBA 10/2021
1	momordicine IIBA 03/2021
1	TenascinIBA 03/2021
1	SmokeIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Retinoblastoma ProteinIBA 12/2020
1	CyclinsIBA 12/2020
1	AngiotensinsIBA 12/2020
1	Therapeutic UsesIBA 07/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	CateninsIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	GlypicansIBA 01/2020
1	Human Serum Albumin FDA LinkGeneric 01/2020
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020

Therapy/Procedure

16	Therapeutics 01/2022 - 06/2006
10	bitter melon extract 11/2019 - 03/2010
2	Drug Therapy (Chemotherapy) 06/2017 - 11/2002
2	Liver Transplantation 03/2015 - 09/2013